Read publication 

Welcome to the April edition of the Baker McKenzie Ukraine Healthcare Industry Group Newsletter. This is your regular digest of legal developments affecting the life science and healthcare industries in Ukraine.

This edition covers the period of March to April 2017 and it is dedicated to the following: the recast of the regulatory framework for reimbursement, pricing and public procurement of pharmaceuticals in Ukraine, changes of the lists of OTC pharmaceuticals and pharmaceuticals prohibited from advertising, the register of persons responsible for entering medical devices into circulation and other new bylaws related to the turnover of medical devices. More details on these developments in the Ukrainian life science and healthcare industries are described below.

In this issue:

  • Recast of the regulatory framework for reimbursement, pricing and public procurement of pharmaceuticals in Ukraine
  • The register of persons responsible for entering medical devices into circulation
  • New lists of OTC pharmaceuticals and pharmaceuticals prohibited from advertising
  • The moratorium on state inspections does not extend to surveillance activities on medical devices
  • Cancellation of MOH orders on the registration of medical devices
Explore More Insight
View All